Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Azithromycin for BPD Prevention in Preterm Infants
NCT06584474Phase 4Completed
- Sponsor
- Alexandria University
- Start
- Oct 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin in bronchopulmonary dysplasia (BPD), sponsored by Alexandria University. Started Oct 2024; status: completed.
02
Drugs
azithromycin
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT06584474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06584474.